Literature DB >> 30544224

Analysis of hidradenitis suppurativa-linked mutations in four genes and the effects of PSEN1-P242LfsX11 on cytokine and chemokine expression in macrophages.

Airong Li1, Yang Peng1, Lauren M Taiclet1, Rudolph E Tanzi1.   

Abstract

Hidradenitis suppurativa (HS), or acne inversa, is a chronic inflammatory skin disorder characterized clinically with acne-like lesions in apocrine gland-bearing skin, follicular occlusion and recurrent inflammation. Thirty-four unique mutations in patients with HS have been found in three genes encoding the γ-secretase complex: nicastrin (NCSTN), presenilin 1 (PSEN1), presenilin enhancer 2 (PSENEN) and in POGLUT1, an endoplasmic reticulum O-glucosyltransferase involved in Notch signaling. We have carried out a system review and have performed a functional analysis of the 34 unique reported HS-linked mutations in NCSTN, PSEN1, PSENEN and POGLUT1. We have also examined the effects of the HS-linked PSEN1-P242LfsX11 mutation on cytokine and chemokine expression in macrophages. Mutations in NCSTN are predicted to cause loss of function, to result in loss of transmembrane (TM) domain, to affect NCSTN substrate recruitment sites, to cause loss or creation of new ligand binging sites and to alter post-translational modifications and disulfide bonds. PSEN1-P242LfsX11 occurs at the opposite side of TM5 from Alzheimer's disease-linked PSEN1 mutations. All of the PSENEN mutations occur on TM regions that are predicted to disrupt membrane function. POGLUT1 mutations lead to an early termination of protein synthesis and are predicted to affect ligand binding function. In addition, PSEN1-P242LfsX11 mediates cytokine and chemokine expression and prolongs tumor necrosis factor α production on the inflammatory processes in THP-1 cells and phorbol-12-myristate-13-acetate-differentiated macrophages in response to lipopolysaccharide stimulation. These in silico analyses are instructive for functional studies of the HS-linked mutations. The PSEN1-P242LfsX11 mutation mediates cytokine and chemokine expression in macrophages.
© The Author(s) 2018. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30544224      PMCID: PMC6423421          DOI: 10.1093/hmg/ddy414

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  53 in total

1.  Mutations in the γ-secretase genes NCSTN, PSENEN, and PSEN1 underlie rare forms of hidradenitis suppurativa (acne inversa).

Authors:  Andrew E Pink; Michael A Simpson; Nemesha Desai; Dimitra Dafou; Alison Hills; Peter Mortimer; Catherine H Smith; Richard C Trembath; Jonathan N W Barker
Journal:  J Invest Dermatol       Date:  2012-05-24       Impact factor: 8.551

2.  Characterization of a Novel Mutation in the NCSTN Gene in a Large Chinese Family with Acne Inversa.

Authors:  Shide Zhang; Jin Meng; Miao Jiang; Jingjun Zhao
Journal:  Acta Derm Venereol       Date:  2016-03       Impact factor: 4.437

Review 3.  Hidradenitis suppurativa: a disease of apocrine gland physiology.

Authors:  Leslie-Ann Lasko; Christopher Post; Sandeep Kathju
Journal:  JAAPA       Date:  2008-11

4.  Confirmation by exome sequencing of the pathogenic role of NCSTN mutations in acne inversa (hidradenitis suppurativa).

Authors:  Yuan Liu; Min Gao; Yong-mei Lv; Xu Yang; Yun-qing Ren; Tao Jiang; Xin Zhang; Bi-rong Guo; Min Li; Qing Zhang; Peng Zhang; Fu-sheng Zhou; Gang Chen; Xian-yong Yin; Xian-bo Zuo; Liang-dan Sun; Xiao-dong Zheng; Shu-mei Zhang; Jian-jun Liu; Youwen Zhou; Ying-rui Li; Jun Wang; Jian Wang; Huan-ming Yang; Sen Yang; Rui-qiang Li; Xue-jun Zhang
Journal:  J Invest Dermatol       Date:  2011-03-24       Impact factor: 8.551

Review 5.  Leukemia inhibitory factor (LIF).

Authors:  Nicos A Nicola; Jeffrey J Babon
Journal:  Cytokine Growth Factor Rev       Date:  2015-07-04       Impact factor: 7.638

6.  A novel NCSTN mutation alone may be insufficient for the development of familial hidradenitis suppurativa.

Authors:  Yukiko Nomura; Toshifumi Nomura; Shotaro Suzuki; Masae Takeda; Osamu Mizuno; Yuka Ohguchi; Riichiro Abe; Yozo Murata; Hiroshi Shimizu
Journal:  J Dermatol Sci       Date:  2014-02-07       Impact factor: 4.563

7.  PSENEN and NCSTN mutations in familial hidradenitis suppurativa (Acne Inversa).

Authors:  Andrew E Pink; Michael A Simpson; Glen W Brice; Catherine H Smith; Nemesha Desai; Peter S Mortimer; Jonathan N W N Barker; Richard C Trembath
Journal:  J Invest Dermatol       Date:  2011-03-17       Impact factor: 8.551

Review 8.  The Genetics of Hidradenitis Suppurativa.

Authors:  John R Ingram
Journal:  Dermatol Clin       Date:  2016-01       Impact factor: 3.478

9.  Mutations in POFUT1, encoding protein O-fucosyltransferase 1, cause generalized Dowling-Degos disease.

Authors:  Ming Li; Ruhong Cheng; Jianying Liang; Heng Yan; Hui Zhang; Lijia Yang; Chengrang Li; Qingqing Jiao; Zhiyong Lu; Jianhui He; Jin Ji; Zhu Shen; Chunqi Li; Fei Hao; Hong Yu; Zhirong Yao
Journal:  Am J Hum Genet       Date:  2013-05-16       Impact factor: 11.025

10.  Novel Mutations in PSENEN Gene in Two Chinese Acne Inversa Families Manifested as Familial Multiple Comedones and Dowling-Degos Disease.

Authors:  Cheng Zhou; Guang-Dong Wen; Lwin Myint Soe; Hong-Jun Xu; Juan Du; Jian-Zhong Zhang
Journal:  Chin Med J (Engl)       Date:  2016-12-05       Impact factor: 2.628

View more
  10 in total

1.  Impact of 970 nm photobiomodulation therapy on wound healing in cellular models of hidradenitis suppurativa.

Authors:  Luisa Zupin; Giulia Ferri; Paola Maura Tricarico; Rossella Gratton; Cécile Nait-Meddour; Giulia Ottaviani; Sergio Crovella
Journal:  Lasers Med Sci       Date:  2020-07-09       Impact factor: 3.161

Review 2.  Botulinum toxin type A for the management of hidradenitis suppurativa.

Authors:  Huanhuan Qu; Lin Gao
Journal:  Am J Transl Res       Date:  2021-12-15       Impact factor: 4.060

3.  Other Types of Glycosylation.

Authors:  Yohei Tsukamoto; Hideyuki Takeuchi
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 3.650

Review 4.  Insights from γ-Secretase: Functional Genetics of Hidradenitis Suppurativa.

Authors:  Gautham Vellaichamy; Peter Dimitrion; Li Zhou; David Ozog; Henry W Lim; Wilson Liao; Iltefat H Hamzavi; Qing-Sheng Mi
Journal:  J Invest Dermatol       Date:  2021-04-07       Impact factor: 7.590

Review 5.  Hidradenitis Suppurativa as a Potential Subtype of Autoinflammatory Keratinization Disease.

Authors:  Toshifumi Nomura
Journal:  Front Immunol       Date:  2020-05-20       Impact factor: 7.561

6.  A novel nicastrin mutation in a three-generation Dutch family with hidradenitis suppurativa: a search for functional significance.

Authors:  P J van der Spek; E P Prens; A R J V Vossen; K R van Straalen; S M A Swagemakers; J E M M de Klein; A P Stubbs; D J Venter; H H van der Zee
Journal:  J Eur Acad Dermatol Venereol       Date:  2020-03-12       Impact factor: 6.166

Review 7.  Hidradenitis suppurativa; classification, remedies, etiology, and comorbidities; a narrative review.

Authors:  Sadaf Mohammadi; Abbas Gholami; Lina Hejrati; Masoomeh Rohani; Raheleh Rafiei-Sefiddashti; Alireza Hejrati
Journal:  J Family Med Prim Care       Date:  2021-11-29

8.  Immunological and prognostic analysis of PSENEN in low-grade gliomas: An immune infiltration-related prognostic biomarker.

Authors:  Kaijie Chen; Beibei Liang; Wenhao Ma; Guoqing Wan; Bing Chen; Changlian Lu; Yuzhou Luo; Xuefeng Gu
Journal:  Front Mol Neurosci       Date:  2022-07-28       Impact factor: 6.261

Review 9.  Innate immunity and microbial dysbiosis in hidradenitis suppurativa - vicious cycle of chronic inflammation.

Authors:  Divya Chopra; Rachel A Arens; Watcharee Amornpairoj; Michelle A Lowes; Marjana Tomic-Canic; Natasa Strbo; Hadar Lev-Tov; Irena Pastar
Journal:  Front Immunol       Date:  2022-07-28       Impact factor: 8.786

Review 10.  Hidradenitis Suppurativa: Current Understanding of Pathogenic Mechanisms and Suggestion for Treatment Algorithm.

Authors:  S Morteza Seyed Jafari; Robert E Hunger; Christoph Schlapbach
Journal:  Front Med (Lausanne)       Date:  2020-03-04
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.